Pfizer explores sale of hospital drugs unit 

Pfizer is considering selling its hospital drugs unit as it faces pressure from activist investor Starboard Value to divest non-core assets. Reuters exclusively reported this move, highlighting the pharmaceutical company’s strategic decision-making amidst industry shifts. This development underscores Pfizer’s focus on streamlining its operations and responding to investor demands for improved performance.

Full Article